8-K filing — ASPEN AEROGELS INC (ASPN)
Filed: 2026-09-15 AccNo: 0001171843-26-006048 Size: 8 MB Item 7.01: Regulation FD Disclosure Item 9.01: Financial Statements and Exhibits
Stocks · News reference
Aspen Aerogels Q2 2026 Earnings Call Transcript
Aspen Aerogels (NYSE:ASPN) reported second-quarter financial results on Thursday. The transcript from the company's second-quarter earnings call has been provided below. This transcript is brought to you by Benzinga
Reference Details
Connected Markets
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
- Source
- benzinga
- Observed
- Checked
- Cadence
- Captured once, then retained as an archive reference
- Status
- fresh
Keep reading
Related Headlines
Barclays Maintains Underweight on Aspen Aerogels, Raises Price Target to $5
Barclays analyst David Anderson maintains Aspen Aerogels (NYSE:ASPN) with a Underweight and raises the price target from $4 to $5.
Crude Oil Gains 2%; Keurig Dr Pepper Earnings Top Views
Dow drops over 300 points, NASDAQ down 0.05% and S&P 500 down 0.19%. Keurig Dr Pepper reports strong Q2 results. Energy sector up, real estate down.